Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous SVF vs CP in Knee Osteoarthritis
NCT07405840Phase 4Active, not recruiting
- Sponsor
- Clinical Center of Vojvodina
- Start
- Jun 2025
- Primary completion
- Aug 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 4, randomised trial of autologous adipose stromal vascular fraction in osteoarthritis (OA) (2 arms), sponsored by Clinical Center of Vojvodina. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index at 12 months. Started Jun 2025; status: active, not recruiting.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07405840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07405840.